Beranda › Artritis Psoriatik › Pennsylvania › Altoona
Uji klinis Artritis Psoriatik di Altoona, PA
6 studi untuk Artritis Psoriatik mencari peserta di lokasi sekitar Altoona (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Menerima pesertaFase 3
- Altoona Center For Clinical Research, Duncansville · 7 mi jauhnya
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Menerima pesertaFase 2
- Altoona Center for Clinical Research ( Site 5110), Duncansville · 7 mi jauhnya
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Menerima pesertaFase 3
- Clinical Site, Duncansville · 7 mi jauhnya
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Menerima pesertaFase 3
- Altoona Center for Clinical Research | Ducansville, PA, Duncansville · 7 mi jauhnya
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Menerima pesertaFase 1
- Pa0019 115, Duncansville · 7 mi jauhnya
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Menerima pesertaFase 2
- Altoona Center For Clinical Research /ID# 272593, Duncansville · 7 mi jauhnya
Uji klinis Artritis Psoriatik di kota lain
- Houston, TX8 studi
- Charlotte, NC7 studi
- Parma, OH6 studi
- Tampa, FL6 studi
- Philadelphia, PA6 studi
- Cleveland, OH5 studi
- Plantation, FL5 studi
- Clearwater, FL5 studi
- New York City, NY5 studi
- San Diego, CA5 studi
- Milwaukee, WI5 studi
- Hialeah, FL4 studi
Studi lain di Altoona
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.